Radiolabeled peptides: valuable tools for the detection and treatment of cancer

Area of Science:

• Oncology
• Radiochemistry
• Molecular Imaging

Background:

• Human cancer cells frequently overexpress peptide receptors, serving as molecular targets.
• Radiolabeled peptides binding to these receptors offer potential for cancer diagnosis and targeted therapy.
• Solid-phase synthesis and bioconjugation enable diverse peptide-based targeting molecule development.

Purpose of the Study:

• To review recent advancements in small peptide applications for cancer diagnosis and treatment.
• To highlight the potential of peptide receptor targeting in nuclear oncology.

Main Methods:

• Investigating various peptide families like somatostatin, bombesin, and RGD for tumor targeting.
• Utilizing solid-phase peptide synthesis, chelating agents, and bioconjugation techniques.
• Exploring peptide-based molecules for diagnostic imaging and radionuclide therapy.

Main Results:

• Several peptide-based targeting agents are under active investigation.
• Peptide targeting demonstrates diverse biological and tumor-specific properties.
• The development of peptide-based agents facilitates targeted cancer interventions.

Conclusions:

• Peptide-based targeting molecules are crucial for advancing nuclear oncology.
• Future applications in cancer diagnosis and therapy are anticipated for these peptides.
• Small peptides represent a promising frontier in targeted cancer management.